Pulmonx
Manu Joshi currently serves as the Sr. Sales Operations Manager at Pulmonx Corporation since March 2021. Prior to this role, Manu held the position of Business Intelligence Manager at Medtronic from August 2015 to March 2021. Manu's career includes experience as Manager of Commercial Operations, Associate Product Manager, and Business Analyst at Covidien (BARRX Medical) from June 2010 to August 2015. Additionally, Manu worked as Senior Credit Manager at Wells Fargo Financial, where financial analysis and operational training were key responsibilities, and as a Mortgage Consultant/Realtor at American Mutual Financial Services. Early career experience includes a role as Campaign Coordinator for CALPIRG, emphasizing environmental advocacy. Manu holds a Master of Business Administration with a focus on Finance and International Business from Santa Clara University and a Bachelor of Arts in Political Science from the University of California, Davis.
This person is not in any teams
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1